Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LBPH

Longboard Pharmaceuticals (LBPH) Stock Price, News & Analysis

Longboard Pharmaceuticals logo

About Longboard Pharmaceuticals Stock (NASDAQ:LBPH)

Advanced Chart

Key Stats

Today's Range
$59.98
$59.98
50-Day Range
$59.50
$59.98
52-Week Range
$27.35
$60.03
Volume
N/A
Average Volume
1.37 million shs
Market Capitalization
$2.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$62.80
Consensus Rating
Hold

Company Overview

Receive LBPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Longboard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LBPH Stock News Headlines

H Lundbeck A/S (HLUNAC.XD)
H. Lundbeck A/S (HLUN-A.CO)
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
See More Headlines

LBPH Stock Analysis - Frequently Asked Questions

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) announced its quarterly earnings results on Thursday, August, 1st. The company reported ($0.56) EPS for the quarter, missing analysts' consensus estimates of ($0.46) by $0.10.
Read the conference call transcript
.

Longboard Pharmaceuticals (LBPH) raised $75 million in an initial public offering (IPO) on Friday, March 12th 2021. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Evercore ISI, Guggenheim Securities and Cantor served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Longboard Pharmaceuticals investors own include JPMorgan Chase & Co. (JPM), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Visa (V) and Home Depot (HD).

Company Calendar

Last Earnings
8/01/2024
Today
9/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LBPH
CIK
1832168
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$90.00
Low Price Target
$44.00
Potential Upside/Downside
+4.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.03%
Return on Assets
-30.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.97
Quick Ratio
15.97

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
35.92

Miscellaneous

Outstanding Shares
39,050,000
Free Float
37,234,000
Market Cap
$2.34 billion
Optionable
Optionable
Beta
1.00
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:LBPH) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners